Trial Profile
A single and multiple-dose ascending clinical pharmacology study of ACT-178882, and its pharmacokinetic interaction with food and midazolam.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 28 Nov 2015
Price :
$35
*
At a glance
- Drugs ACT 178882 (Primary) ; Midazolam
- Indications Hypertension
- Focus Pharmacokinetics
- 28 Nov 2015 New trial record